Ethylene glycol residue testing is a critical quality control measure for traditional Chinese medicine (TCM) materials, herbal extracts, and finished herbal products, ensuring compliance with strict pharmacopoeial residual solvent limits. This technical article provides a comprehensive overview of sample types, regulatory standards, analytical methods, and practical applications for accurate ethylene glycol quantification in Chinese herbal medicines.
Technical Overview
Ethylene glycol (CAS No. 107-21-1) is a highly polar diol widely used in industry as an antifreeze agent, extraction co-solvent, and chemical intermediate. In pharmaceutical quality control, it is classified as a Class 2 residual solvent under the ICH Q3C guideline, with a permitted daily exposure (PDE) of 6.2 mg/day and a concentration limit of 620 ppm. Due to its nephrotoxicity—ethylene glycol is metabolized in vivo to glycolic and oxalic acids, causing acute kidney injury and metabolic acidosis—even trace residues in herbal medicines must be strictly monitored and controlled.
Residual ethylene glycol in Chinese herbal materials may originate from several sources, including:
- Extraction and concentration processes that employ glycol-based co-solvents or heat transfer fluids;
- Contaminated pharmaceutical excipients such as glycerin or propylene glycol used in syrups, oral liquids, and soft capsules;
- Equipment cleaning agents and lubricants that are not adequately removed during production;
- Migration from primary packaging materials such as plastic containers, liners, and films;
- Solvent substitution or adulteration during herbal processing and manufacturing.
Testing is performed in accordance with the residual solvent determination requirements of the Chinese Pharmacopoeia (ChP), as well as ICH Q3C(R8), USP General Chapter 467, and Ph. Eur. 2.4.24, ensuring that products satisfy both domestic and international market requirements.
Testing Samples
Raw Herbal Materials and Decoction Pieces
Whole or sliced crude drugs, including roots, rhizomes, barks, flowers, fruits, seeds, and whole plants. Samples are homogenized and milled to a uniform particle size before extraction to ensure representative and reproducible results.
Herbal Extracts and Concentrated Powders
Standardized extracts, granules, and concentrated powder intermediates produced by water or hydro-alcoholic extraction. These matrices frequently carry over processing solvents and therefore require direct residue monitoring at the intermediate stage.
Chinese Patent Medicines and Finished Dosage Forms
Tablets, capsules, oral liquids, syrups, tinctures, drops, and pills containing TCM ingredients. Liquid dosage forms formulated with glycerin or propylene glycol excipients are of particular concern for glycol contamination and are prioritized for screening.
Pharmaceutical Excipients and Process Intermediates
Glycerin, propylene glycol, polyethylene glycols, processing solvents, and in-process materials that may introduce ethylene glycol or related glycols such as diethylene glycol (DEG) into the final herbal product.
Testing Items
A complete ethylene glycol residue testing program covers the following items:
- Ethylene glycol residual content, quantified and reported in ppm (mg/kg) for comparison against the 620 ppm limit;
- Screening of related glycol impurities, including diethylene glycol and propylene glycol, where the product matrix or formulation warrants it;
- Identification of unknown volatile impurities when abnormal chromatographic peaks or out-of-specification results are observed;
- Method validation attributes, including specificity, linearity, range, accuracy, precision, limit of detection (LOD), and limit of quantitation (LOQ).
Acceptance criteria are established based on the maximum daily dose of the product: the measured ethylene glycol concentration multiplied by the total daily intake must not exceed the PDE of 6.2 mg/day.
Testing Methods
Gas Chromatography with Flame Ionization Detection (GC-FID)
GC-FID is the primary technique for ethylene glycol determination. Samples (typically 0.5–1.0 g) are extracted with water or aqueous methanol by ultrasonication for 20–30 minutes, centrifuged, and filtered through a 0.45 micrometer membrane before direct injection. Separation is achieved on a polar polyethylene glycol (PEG-type) capillary column, such as a 30 m × 0.32 mm × 0.25 micrometer DB-WAX or equivalent, with an internal standard such as 1,4-butanediol compensating for injection variability. Typical LOQ values of 20–50 ppm are achievable in relatively clean matrices.
Headspace Gas Chromatography
Static headspace GC minimizes matrix interference from non-volatile herbal constituents such as sugars, tannins, and pigments. Because ethylene glycol has low volatility (boiling point 197.3°C), headspace conditions require elevated equilibration temperatures (80–100°C) and extended equilibration times (30–60 minutes) to achieve adequate sensitivity.
Derivatization-Assisted Chromatography
For complex matrices or low-level detection requirements, ethylene glycol is derivatized to more volatile and detectable species, commonly through silylation (for example, with BSTFA containing 1% TMCS) to form bis-trimethylsilyl ethers, or through cyclic boronate ester formation with phenylboronic acid. Derivatization typically lowers the LOQ to below 10 ppm.
GC-MS and HPLC Confirmation
GC-MS operated in selected ion monitoring mode provides unambiguous identity confirmation and is used to resolve co-eluting matrix peaks. HPLC with refractive index detection or evaporative light scattering detection, employing carbohydrate or ion-exclusion columns, serves as an orthogonal technique when thermal instability or severe matrix effects limit GC performance.
Method Validation and Quality Assurance
All methods are validated in accordance with ICH Q2(R2) requirements. Typical acceptance criteria include a correlation coefficient of at least 0.999 for linearity, spike recoveries between 85% and 110%, and relative standard deviations below 10% for repeatability. Every analytical batch incorporates system suitability checks, multi-point calibration, reagent blanks, and spiked recovery samples to guarantee data integrity.
Applications
- Batch release testing of herbal extracts and Chinese patent medicines for regulatory compliance;
- Supplier qualification and incoming material control for crude drugs, extracts, and glycol-containing excipients;
- GMP in-process monitoring during extraction, concentration, granulation, and drying operations;
- Investigation of out-of-specification results and contamination or adulteration incidents;
- Support of product registration dossiers, pharmacopoeial compliance statements, and export certification;
- Long-term and accelerated stability studies to track residual solvent behavior over the product shelf life.
FAQ
What is the regulatory limit for ethylene glycol in Chinese herbal medicines?
Under ICH Q3C, which is aligned with the Chinese Pharmacopoeia residual solvent requirements, ethylene glycol is a Class 2 solvent with a PDE of 6.2 mg/day, corresponding to a concentration limit of 620 ppm for a product with a daily intake of 10 g. For products with higher daily doses, the permitted concentration is proportionally lower.
Why is ethylene glycol sometimes found in herbal products?
Common causes include carryover from glycol-based extraction or processing solvents, contamination of glycerin or propylene glycol excipients with ethylene glycol or diethylene glycol, inadequate equipment cleaning, packaging migration, and unauthorized solvent substitution during manufacturing or herbal processing.
Which analytical method is most suitable?
GC-FID with direct liquid injection is suitable for most extracts and finished products. Headspace GC is preferred for matrices rich in non-volatile constituents, while derivatization GC or GC-MS is recommended when detection limits below 20 ppm or confirmatory identification are required.
How are difficult herbal matrices handled?
Interference from sugars, organic acids, and pigments is controlled through matrix-matched calibration, standard addition quantification, solid-phase extraction or dispersive clean-up, strategic dilution, and orthogonal confirmation by GC-MS or HPLC.
How long does testing take and how much sample is required?
Typical turnaround time is 5–10 working days, covering sample preparation, analysis, validation checks, and reporting. A minimum of 5–10 g of homogeneous sample material is generally required, with additional quantities retained for confirmation testing if needed.
